Non-Listed Alternatives (West)
Dana Point, CA
December 4 - 5, 2019

Description

We are pleased to announce our 15th Annual Western Non-Traded REITs & Retail Alternative Investment Symposium: December 4-5, 2019 in Dana Point, CA.

As the retail alternative investment industry continues its dynamic evolution, new opportunities are opening up as others pullback. One thing is for certain: it isn’t business as usual.

How are both the product offering and distribution sides of the market evolving? What does this mean for product sponsors, IBDs/RIAs and retail investors? What should industry stakeholders now be doing to prepare for change and to take advantage of new opportunities as they are presented?

Join industry heads December 4-5 in Dana Point, CA as we discuss these critical issues and others.

Who Should Attend
  • Broker Dealers
  • Financial Advisory Firms
  • Financial Planners
  • Non-Traded REITs

Conference Highlights

Networking Tutorial

    Platform Introduction

    LOADING MEDIA...

    Getting Started

    LOADING MEDIA...

    Updating Personal Info

    LOADING MEDIA...

    Updating Demographics

    LOADING MEDIA...

    Searching By Name/Company

    LOADING MEDIA...

    Filter By Demographics

    LOADING MEDIA...

    Send Invitation

    LOADING MEDIA...

    Accept Invitation

    LOADING MEDIA...

    Messaging Connections

    LOADING MEDIA...

    Post Conference Content

    LOADING MEDIA...

My Agenda

  • To view your agenda you must be signed in Sign-In

Agenda

    Preliminary Agenda

       

      • Big Picture – Market Trends/Update



        ** This session contains presentations. Presentations will be made available to conference registrants starting first day of the conference.

      Year-End Market Update & State of the Retail Alternative Investment Industry Address

        • Who were the winners and losers in the non-listed alts universe this year? What’s attracting capital? What are noteworthy distribution trends across channels?
        • 2019 was a strong year across many non-listed products: What factors were behind the uptick in sales? What is current retail investor sentiment? What can we expect in 2020?
        • What are the market-impacting factors of 2020 to watch closely? What will be the impact of the general election year on the non-listed alts market?
        • What are rising asset types within non-listed alts products? Cannabis? ESG/sustainability-orientated investments? Other? What are the investment trends to look for in 2020-2021?
        • Publics vs. privates: Key trends to watch
        • BDCs: What’s next for this product?
        • Qualified Opportunity Zones: Where does this market stand? Has it been worth the hype?
        • What new products are in registration? Anything notable? What further innovation can we expect and along what lines?
        • Who are the new/up-and-coming market entrants? Who are the ones to watch? Is the retail alt industry becoming institutionalized?
        • Consolidation, conversions and amendments to filings: The latest on how sponsors continue to adapt their business model; What has been the response amongst distributors/retail investors? What further adaptation can we expect?
        • Exits: The latest




        ** This session contains presentations. Presentations will be made available to conference registrants starting first day of the conference.

      Issues To Watch: Factors That Could Impact Retail Alts Reach Amongst Investors

      • In this session we take a forward-looking approach to key issues that have the potential to expand – or contract – non-listed alts’ reach to retail investors. In discussing these points we also address what sponsors and distributors need to be considering and possible steps forward.
        • Making private markets more accessible to retail investors: The latest from the SEC
        • Regulation Best Interest and state-level initiatives: An update*
        • When will defined contribution plans start to include direct participation programs (DPPs)? What will it take for this to happen? How can DPPs better position themselves for inclusion?
        • Robo-advisors: When will they place non-listed alts on their platform? What can the industry do to facilitate this?




        ** This session contains presentations. Presentations will be made available to conference registrants starting first day of the conference.

       

      • Product Sponsor Strategy



        ** This session contains presentations. Presentations will be made available to conference registrants starting first day of the conference.

      Product Sponsor President & CEO Perspective: Strategies For The Next Decade

        • Is a recession coming? To what degree do non-listed alts offer protection to retail investors? Are some product types/investment strategies better-positioned to offer protection than others?
        • How are you preparing for a possible downturn? Will the fact that 2020 is a general election year have any impact on your strategy?
        • What returns are realistic in the current uncertain climate? How are you setting retail investors’ expectations?
        • What further institutionalization of the non-listed retail alts market can we expect? Will the barriers to market entry soon be too great for non-institutional players?
        • Reaching new retail investors vs. expanding allocations from your existing investors: Where are you focusing efforts? What investments are you making in investor education? Investments in penetrating new distribution channels? What have you found to be successful?
        • What is your strategy for getting retail investors’ capital back? What percentage of your investors are reinvesting with you? Any notable trends in where your investors are (re)investing capital?
        • Are there any untapped opportunities within the non-listed alts market today? Where will you be focusing your efforts for the next 12-24 months?
        • What further evolution will we see in the retail non-listed alts industry? Where is the industry headed? What do you see as its greatest threats? Can we learn anything from the past 10 years as an indicator of what to expect over the next 10 years?
        • As we enter a new decade, where do you see your organization in 2030?




        ** This session contains presentations. Presentations will be made available to conference registrants starting first day of the conference.

      Product Sponsor & Managing Broker/Dealer Perspective: Overcoming Operational Challenges & Other Innovative Approaches to Expanding Into New/Multiple Distribution Channels

        • What are the operational challenges of expanding into new distribution channels?: RIAs; Wirehouses; Family Offices; crowdfunding sites
        • What innovative approaches to back-office functions/streamlining processes are helping sponsors penetrate new distribution channels?
        • What are the non-operational challenges for sponsors distributing non-listed alts via different distribution channels (RIAs/Family Offices, etc.)? How does it differ to distributing via IBDs? 
        • Expanding RIA, Wirehouse and Family Office interest in your non-listed alts product: Do’s/don’ts
        • Forming relationships and communicating with RIAs, Family Offices and Wirehouses: How are these processes different to that with IBDs?
        • What do wholesalers and national accounts managers need to understand and do in their approach to and ongoing communication with RIAs, Family Offices and Wirehouses? How can sponsors better train their sales teams to work with such channels/clients?
        • Getting on custodial platforms: What are the key considerations/steps for non-listed alts sponsors? What are the steps for sponsors to properly structure relationships with custodians? How are custodians viewing non-listed alts today?




        ** This session contains presentations. Presentations will be made available to conference registrants starting first day of the conference.

      New Product Sponsors: The Economics (And Reality) Of Market Entry Today

        • Launching private/public offerings vs. investing deal-by-deal: What is the business case today?
        • What are the pros/cons of launching private vs. public offerings? How do upfront/ongoing costs; fees; timeframes; structuring processes, etc. compare?
        • What scale is necessary to make a new product financially viable today? When can you expect to see a return?
        • How best to put real estate/debt into a retail investor’s portfolio? Which wrapper? Asset types?
        • Selecting service providers: Who do you need? What to look for?
        • Can new sponsors function without a wholesaling broker/dealer? Having an internal broker/dealer vs. outsourcing to a managing broker/dealer
        • How can new sponsors (no track record) and/or non-brand name products get on distributors’ radars?
        • Going the crowdfunding route
        • How imperative is it that sponsors get placed on custodial platforms in today’s market? What advantages do transfer agents offer?
        • End game plan/exits




        ** This session contains presentations. Presentations will be made available to conference registrants starting first day of the conference.

       

      • Meeting Retail Investors’ Investment Needs



        ** This session contains presentations. Presentations will be made available to conference registrants starting first day of the conference.

      How Sponsors & Distributors Can Meet The Changing Investment Wants & Needs Of Different Types Of Retail Investor

      • What are retail investors’ investment preferences today and how do they differ between the different types of investor (Family Office, HNW, mass affluent, millennials, baby boomers, etc.)? Is there a difference in how they view investments in the current macro-economic environment and at this stage in the market cycle? What are notable trends in product structures and asset types being preferred by the different investor types? Who’s opting for public vs. private markets? How important is a product sponsor’s name? Track record? To what degree will the election year impact investment choices? Are ESG/sustainability-focused investments gaining traction in any group? And with new distribution channels and innovative technology broadening the range of methods by which to invest (via IBDs/RIAs/online technology, etc.), what are the different retail investors opting to do? How can product sponsors better position themselves to penetrate the different retail investor groups? What should IBDs/RIAs add to their platforms for their client base? Engagement and communication strategies?



        ** This session contains presentations. Presentations will be made available to conference registrants starting first day of the conference.

      A Roundtable Discussion: Solving Income and Capital Gains Tax Issues for High Income Individuals and Entities

      • In this session we address using Qualified Opportunity Zone funds, 1031 exchanges, Conservation Easements, Oil and Gas Drilling Programs and Tax Credits to solve income and capital gains tax issues for high income individuals and entities. Active audience participation is encouraged.



        ** This session contains presentations. Presentations will be made available to conference registrants starting first day of the conference.

       

      • IBD/RIA/Family Office/Advisor Perspective



        ** This session contains presentations. Presentations will be made available to conference registrants starting first day of the conference.

      The RIA Viewpoint: Overcoming The Operational & Client-Facing Challenges Of Selling Non-Listed Alts

      • From due diligence and underlying asset evaluation to reporting, compliance, tax issues, paperwork processing, and engaging and educating clients – the non-listed alts learning curve for RIAs can be considerable. In this session a panel of RIAs discuss the operational challenges they have overcome in adding non-listed alts to their platform and the client education issues they continue to address.
        • What is the business case for RIAs to sell non-listed alts to their clients?
        • What is the learning curve that RIAs have around non-listed alt products?
        • What have been the key operations challenges in offering non-listed alts to your clients?
        • The key client engagement/education challenges?
        • How can product sponsors help RIAs overcome such operations/client education challenges?
        • What other resources are available for RIAs?




        ** This session contains presentations. Presentations will be made available to conference registrants starting first day of the conference.

      RIAs & Family Offices

        • Is there a viable distribution channel for RIA/family office focused, fee-based programs specifically for RIAs that are not dually licensed? If so, what is working and what isn’t? What does the load have to look like?
        • How can product sponsors make their offerings more attractive to family offices/RIAs, particularly in the current climate? What product types/structures/assets are being favored? What are common must-have features? Buy or deny criteria?
        • How are family offices really sourced and converted? What intermediaries do sponsors often have to go through?
        • Are family offices worth the time/effort/cost to secure and maintain as an investor? What is the business case for having a dedicated effort to securing family offices? 
        • How are alternatives being used in advisor accounts? How are they being priced? Managed? How are ongoing fees being collected?
        • What client servicing needs/expectations do family offices/RIAs have for their investments?




        ** This session contains presentations. Presentations will be made available to conference registrants starting first day of the conference.

      An Advisor’s Guide To Alternative Investment Product Wrappers & Their Use In Investors’ Portfolios Today

        • What constitutes a balanced portfolio for retail investors in the current macro-economic climate? What role should alternatives play?
        • Assessing the pros and cons of different alt product structures in terms of risk; liquidity, cost, etc. for retail investors in the current economic environment
        • Which wrappers offer retail investors the greatest protection in a market downturn?
        • How to determine if a wrapper may/may not be the best structure for the underlying assets?
        • How to determine if a wrapper may/may not be suited to a particular client?
        • Which wrappers are proving particularly popular amongst retail investors? Which are stalling/failing to gain traction? Why?
        • Understanding the key regulatory differences and pressures for the various product structures
        • “I like the underlying assets but not the wrapper.” What next?
        • Getting comfortable with a product wrapper: The critical boxes that need to be checked




        ** This session contains presentations. Presentations will be made available to conference registrants starting first day of the conference.

      Advisor/Registered Rep Perspective: Selling Non-Listed Alts Today

        • How are you viewing non-listed alts today and how are you using them in client portfolios?
        • Are certain non-listed alt product types resonating with you/your clients more than others?
        • What are your clients’ investment sentiments about the current economic environment/stage of the cycle?
        • How are you/your clients viewing different asset types? Are particular assets and sub-groups being favored?
        • How are you determining if the wrapper and underlying assets are the best match for your clients in terms of investment time horizons, risk-return tolerances and yield expectations?
        • What opportunities do alternatives offer advisors? For advisors who are not yet on the alternative bandwagon, what advice would you give them?
        • What challenges do you face in selling alternatives? Is there a particular client type who seems more/less receptive to non-listed alts than others? What is common feedback from clients?
        • What do product sponsors and IBDs/RIAs need to understand about how advisors recommend and sell alternatives to their clients?
        • What will it take for you to take your sales of alts to the next level and what do you need from product sponsors and IBDs/RIA to achieve this?




        ** This session contains presentations. Presentations will be made available to conference registrants starting first day of the conference.

      IBD Perspective: Product Stress Testing; Evolving Platforms; Investor Education

        • What is your sentiment about non-listed alts as we head into 2020? What are the key factors influencing this?
        • What product stress-testing measures are you employing in the event of a market downturn? Are you revisiting your platform? Risk parameters?
        • How are you approaching Regulation Best Interest and states’ related initiatives? Are you becoming/will you become more cautious about non-mainstream investment products?
        • How are you now viewing Qualified Opportunity Zone (QOZ) investments? What has been the response of your family office/HNW/retail investor clients to such products?
        • Are retail investors focusing more on investment strategy vs. product structure in the current climate? Are there any investment or product strategies that you are showing greater interest in? Less interest?
        • How are you educating retail investors on the place of non-listed alts in their portfolio? To what degree do your clients now accept such investments as being integral to their portfolio? Is there a difference between generations in the education and acceptance of non-listed alts?
        • How should advisors be advising their clients at this stage in the cycle? What guidance are you giving on what to sell/not sell?
        • What investments are you making in new technology and for what purpose?
        • What advice would you give product sponsors wanting to ‘stand out’ in an increasingly crowded marketplace?




        ** This session contains presentations. Presentations will be made available to conference registrants starting first day of the conference.

       

      • Due Diligence/Stress Testing



        ** This session contains presentations. Presentations will be made available to conference registrants starting first day of the conference.

      Roundtable: Due Diligence & Underlying Asset Valuation In An Increasingly Complex and Varied Non-Listed Alts Market: Real Estate, Credit and Energy-Focused Investment Products

      • This session is open to ALL attendees. Participants are highly encouraged to submit questions/topics in advance. To register and to submit discussion points, please email maggie.donlon@imn.org.



        ** This session contains presentations. Presentations will be made available to conference registrants starting first day of the conference.

      IBD/RIA Closed Door: Due Diligence, Compliance And Regulatory Knowledge Exchange 2020

      • This session is intended to be an information exchange between attendees with particular emphasis on trouble-shooting issues for new and recent entrants to the field. Due diligence, compliance and regulatory executives from IBDs and RIAs address key issues and challenges in their areas of expertize today, and in doing so discuss possible approaches to common obstacles. What are the market-impacting factors to watch closely? What do the due diligence, compliance and regulatory affairs officers of today need to know/understand/do? How have these roles and their challenges changed over the past decade? What do the new generation of such officers need to know and act upon? All participants are encouraged to be actively involved in the conversation. Participation is strictly limited to qualified independent broker/dealers, registered reps, IARs and RIAs (who do not also sponsor proprietary products.) To register and to submit discussion points, please email: dettinger@imn.org



        ** This session contains presentations. Presentations will be made available to conference registrants starting first day of the conference.

      IBD/RIA Closed Door: Product Due Diligence & Stress Testing In An Uncertain Climate

      • All participants are encouraged to be actively involved in the conversation. Participation is strictly limited to qualified independent broker/dealers, registered reps, IARs and RIAs (who do not also sponsor proprietary products.) To register and to submit discussion points, please email: dettinger@imn.org



        ** This session contains presentations. Presentations will be made available to conference registrants starting first day of the conference.

       

      • Investment/Product/Asset-Specific Sessions



        ** This session contains presentations. Presentations will be made available to conference registrants starting first day of the conference.

      Deep Dive Product Update: NAV/Lifecycle REITs; Interval Funds; Private Placements; Preferred Stock Offerings; and BDCs

      • This new product-centric session takes a deep dive approach to the latest key happenings, strategies, performance and outlook for different types of non-listed alts. In providing a strategic summary for each product type, our panel attempts to determine the value proposition that each product offers retail investors today. Talking points include:
        • How are sponsors positioning for market/economic/regulatory factors likely to impact performance and capital raising in 2020?
        • Product/investment strategies and innovation: What is/isn’t gaining traction amongst retail investors? 
        • Stress-testing for an uncertain economic climate
        • Exits: How are sponsors returning capital to investors?
        • In summary: The value proposition to retail investors, especially compared to similar products




        ** This session contains presentations. Presentations will be made available to conference registrants starting first day of the conference.

      Evaluating Core Vs. Core+ Vs. Value Added Vs. Opportunistic Investment Strategies In Today’s Market

      • What are sponsors’ underwriting strategies in this protracted cycle with prices at historic levels? How can IBDs/RIAs effectively evaluate risk within investment strategies and determine what is best for their retail clients with numerous factors affecting investment potential to consider?
        • What are core/core+/value added/opportunistic investment strategies in today’s climate? How to accurately define value added?
        • How are sponsors adding value to assets? How can IBDs/RIAs effectively evaluate value added investment strategies?
        • Are some stabilized assets more risky than opportunistic assets in certain markets in the current climate/cycle? How to determine risk?
        • Sponsors: What are your asset underwriting strategies? What pillars do you look for before you take a position on an asset? What do due diligence officers at IBDs/RIA need to understand about sponsor underwriting processes? 
        • How can IBDs/RIAs navigate the different investment strategies and risk factors at this stage in the cycle? How best to include in clients’ portfolios?
        • What returns are realistic for core/core+/value add/opportunistic today? Will the dial for any move in the near-term?
        • What is the capital raising environment for core/core +/value added/opportunistic products amongst retail investors? Are certain investment strategies gaining favor?




        ** This session contains presentations. Presentations will be made available to conference registrants starting first day of the conference.

      DSTs/1031s: Due Diligence; Innovation; Protections In A Downturn

        • How to make the economics of DSTs work in the current high-price, rising interest rate climate?
        • Preparing for a downturn: Buyer beware? How are/should 1031/DST sponsors build protections for retail investors into their offerings?
        • Exits: Will we see more in 2020? Why now?
        • How are broker/dealers and RIAs approaching due diligence challenges at the property level? What are the valuation pitfalls to avoid, especially at this stage in the cycle? What are common red flags for distributors in 1031/DST offerings?
        • With a rapidly expanding market how great is the risk that 1031 sponsors may compromise on asset/program quality and/or distributors compromise their due diligence to meet the growing demand from retail investors?
        • Examining recent innovations within 1031/DST offerings and assessing their true benefits for retail investors
        • What further product and market evolution are we likely to see within 1031s/DSTs?
        • What will it take for RIAs and wirehouses to fully jump on board the 1031/DST bandwagon?
        • The secondary market for DSTs/1031s: The only way is up?




        ** This session contains presentations. Presentations will be made available to conference registrants starting first day of the conference.

      Energy Investment Opportunities: Sponsor & IBD/RIA Perspectives

      • As the energy sector continues to evolve, so too do the investment opportunities that it offers. In this session we examine the different types of energy investment product now available in terms of their structure and investment focus. We address how these offerings differ, who they are targeted towards, where they fit in investors’ portfolios, what IBDs and RIAs look for in such products and what it takes for them to get comfortable with them. We will also discuss what influences the macro-economic climate and policy initiatives of the current Administration are having on the investment potential of this sector in the short-medium term.



        ** This session contains presentations. Presentations will be made available to conference registrants starting first day of the conference.

      Qualified Opportunity Zones (QOZ) Investments: Due Diligence; Structuring: Winners & Losers

        • What can we learn from the first QOZ funds to launch? Are there winners and losers? Are QOZ investments worth the hype for product sponsors? Distributors?
        • Why the diversity of opinion amongst distributors on the place of QOZs on their platform? What is the right balance?
        • What types of retail investor are (un)suitable for QOZ investments? Are certain kinds of distributors better positioned to sell QOZs than others? Are certain types of sponsor better positioned to offer such products?
        • What are the QOZ product structuring considerations? Does any structure offer advantages over other structures?
        • What is the due diligence process for distributors? How to determine if a sponsor has the sufficient experience? To identify risks in any given QOZ investment? What are QOZ investment/sponsor red flags for you?
        • What are sponsors’ QOZ due diligence factors? As a sponsor, how are you underwriting deals?
        • “The sooner you invest in QOZs, the better the tax break and the better the fund”: Is this accurate? Is the window closing on QOZ investments? What opportunities remain?




        ** This session contains presentations. Presentations will be made available to conference registrants starting first day of the conference.

      ESG & Sustainability Investing: The Next Big Thing In The Non-Listed Alternatives Industry?

        • What is the business case for non-listed alt product sponsors to offer Environmental, Social and Corporate Governance (ESG) and sustainability investing-focused products?
        • The latest trends in ESG and sustainability investing within the non-listed alternatives industry
        • To what degree are ESG and sustainability issues impacting retail investors’ investment decisions? Where is this heading?
        • Are distribution channels placing greater emphasis on ESG and sustainability issues when selecting products/sponsors for their platforms? Is a portion of their product selection dedicated to ESG/sustainability-focused offerings?
        • What sponsor-level and product-level ESG/sustainability information are distributors requesting from sponsors?
        • Not all are created equal: What due diligence issues specific to ESG/sustainable investing products/sponsors do distributors need to understand?
        • What do retail investors want to know about ESG and sustainable investing? How are advisors effectively engaging retail investors and communicating with them on such investments?
        • How can advisors determine which ESG/sustainable investing products are right for their retail clients?
        • Sustainability/ESG oversight/management/reporting; What more can product sponsors be doing to incorporate such initiatives/disclosures at the company level and product level?
        • The SEC’s focus on ESG and sustainability issues: What does this mean for sponsors and distributors? What else can we expect from the SEC on ESG and sustainability and when?




        ** This session contains presentations. Presentations will be made available to conference registrants starting first day of the conference.

      Comparing & Contrasting Non-CRE Non-Listed Alt Products: What Is Their Value Proposition Relative To Real Estate-Focused Offerings For Retail Investors Today?

      • In this session we offer insight into non-real estate-based non-listed alt products. In doing so, we compare them to real estate-based non-listed offerings as an investment for retail investors. Areas addressed: risk-reward profiles; factors impacting investment potential; how sponsors evaluate deals; the economics of such offerings; and what distributors need to consider in conducting due diligence.
        • Credit
        • Energy-related
        • Insurance-linked securities
        • Cannabis
        • Infrastructure/Timber/Agriculture
        • Specialty/Other




        ** This session contains presentations. Presentations will be made available to conference registrants starting first day of the conference.

       

      • Tech & Operations



        ** This session contains presentations. Presentations will be made available to conference registrants starting first day of the conference.

      Advancements & Next Steps In Blockchain Adoption Within The Non-Listed Alts Industry

      • At this event last year we discussed current and potential applications of Blockchain in the non-listed alts industry, along with hurdles to overcome and next steps. A year on, where do things stand? From ‘democratizing real estate investing’ to offering greater transparency and streamlining back office functions, the applications of Blockchain for product sponsors, distributors and retail investors are far-ranging. This session will discuss the latest in the adoption of Blockchain in different facets of the non-listed alts industry, advancements in overcoming hurdles, steps to adoption and what industry stakeholders need to be aware of to not be left behind.



        ** This session contains presentations. Presentations will be made available to conference registrants starting first day of the conference.

      Best Practices in Cybersecurity & Managing IT Risk for Product Sponsors & Distributors

        • Cybersecurity basics: Where do the risks lie? What data needs to be secured? What are key areas of focus for the SEC and FINRA
        • Cyber-risk assessment: Identifying internal vulnerabilities vs. third party/vendor risk
        • Implementing an information security governance framework
        • Technical controls to protect data and the hardware/software on which it is stored/processed
        • Implementing policies and procedures for detecting and responding to incidents; Steps to improve response times
        • What are the cybersecurity/IT risk management responsibilities of registered representatives and IARs? What steps should they be taking?
        • Disclosures/educating retail investors on cyber-based risk
        • Vendor management and due diligence
        • Cyber-insurance: What it is, what it covers and when to consider
        • What can we learn from recent cybersecurity breaches?




        ** This session contains presentations. Presentations will be made available to conference registrants starting first day of the conference.

Sponsors

Register

To register for this conference you must be signed in

  • Super Early Bird Registration - $1,795
  • Early Bird Registration - $1,895
  • Standard Registration - $1,995
Sign-In

Advisory Board

Contact Us

Venue

  • Conference Venue
  • Monarch Beach Resort


    1 Monarch Beach Resort
    Dana Point, CA, 92629
    USA

    Additional Info:

    Please use the link above to make a reservation in our group room block, pending availability, until our cutoff date of Monday, November 4th.  A one (1) night room and tax deposit is required at time of booking. Cancellation is 30 days prior to arrival and any cancellation within 30 days will forfeit the aforementioned deposit and is non-refundable.   IMPORTANT NOTE: IMN has not retained a third party booking company to assist with reservations.  If you are interested in making a reservation at Monarch Beach Resort you must make your reservation using the link above.

1120 Avenue of the Americas, 6th Floor, New York, NY 10036
Tel: +1(212)901-0506 Fax: +1(212)768-2484
Email: mail@imn.org


View Full Site
You need to login before accessing this section. Click "Login" from bottom menu.

Please sign in

Create Account Recover Password Sign in with LinkedIn

Enter Your Email: